Skip to main content
. 2020 Mar 12;20:65. doi: 10.1186/s12876-020-01201-6

Table 5.

Empirical antibiotic treatment

Frequency
(n)
Mono vs. combinational therapy
 Mono 59.4% 136
 Combinational 40.6% 93
 2 drugs 33.6% 77
 ≥ 3 drugs 7.0% 16
Prescribed antibiotic substances
 Cephalosporinea 25.8% 59
 Piperazillin/tazobactam 23.6% 54
 Fluorochinolon 21.4% 49
 Carbapenem 18.8% 43
 Metronidazole 18.8% 43
 Ampicillin/sulbactam 16.2% 37
 Vancomycin 9.2% 21
 Other 14.8% 34

A total of 229 patients were studied

a2nd or 3rd generation